Asensus Surgical (TRXC) Resumes The Uptrend After The Positive News

The medical devices sector has grown at a remarkable rate in recent years and investors are increasingly looking for companies they can invest in. One company that could be tracked at this point is that of Asensus Surgical Inc (NYSE: TRXC).

Yesterday, the Asensus stock gained as high as 16% after the company made a major announcement with regards to one of its products. The company announced that the Senhance Surgical System has been provided with an additional clearance by the United States Food and Drug Administration. It is a significant boost for the company since the latest clearance from the FDA is going to allow the usage of the platform in case of general surgeries in the United States as well.

Related:  Tenax Therapeutics Without Revenue Gets Soaring Stock (NASDAQ: TENX)

The technology platform in question is the first product in its category and has given Asensus a unique opportunity to gain market share in the near term. Investors could consider keeping an eye on the Asensus stock today considering the price action on Wednesday.

Michael Rowels

Weekend Contributor. Writing for business and finance publishers has become his passion over the last decades after he completed a master's degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.